The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.68
Bid: 42.72
Ask: 42.84
Change: 1.06 (2.55%)
Spread: 0.12 (0.281%)
Open: 42.28
High: 42.84
Low: 42.12
Prev. Close: 41.62
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

19 Jul 2016 07:00

RNS Number : 4948E
Assura PLC
19 July 2016
 

19 July 2016

 

Assura plc

 

Trading Update

For the first quarter to 30 June 2016

 

Continued strong growth

 

Assura plc ("Assura"), the UK's leading primary care property investor and developer, today publishes a trading update for the first quarter to 30 June 2016.

 

Value enhancing investment activity

 

Assura continued to make good progress in the first quarter, completing the acquisition of 30 medical centres for a gross consideration of £65.4 million with a passing rent roll of £4.1 million and a weighted average unexpired lease length of 14.1 years.

 

Assura has a further pipeline of individual asset acquisitions and developments currently in solicitors' hands worth £105 million.

 

Rental income increased

 

Assura now owns 351 medical centres with a total annualised rent roll of £68.4 million (31 March 2016: £63.8 million), with growth in the financial year to date driven primarily by acquisitions. In addition, we are maximising income through active asset management: the letting of vacant space has been a particular focus in the first quarter with £0.3 million in new lettings secured in the period.

 

The weighted average annual rent increase was 1.43% on the basis of 32 reviews settled in the quarter, of which open market rents reviews were 1.30%.

 

Strong financing and debt position

 

On 18 May 2016 we secured a new £200 million revolving credit facility on an unsecured basis to replace the existing facility. The initial margin is 150 basis points, which is a reduction of 20 basis points from the previous facility, and the facility increases operational flexibility and reduces transaction costs associated with financing properties. Undrawn facilities currently stand in excess of £115 million.

 

At 30 June 2016, Assura's loans stood at £411.9m, with a weighted average cost of debt of 4.55% (31 March 2016: 4.84%) and a weighted average debt maturity of 10.2 years. At the same date, Assura's proforma net loan to value ratio was 33% (31 March 2016: 30%).

 

Market background

 

We have seen no direct impact to date from the recent EU referendum, although we realise that the result may create political and economic uncertainty, which could affect investment in primary care infrastructure. However, the need for investment in primary care premises is recognised by the NHS as a priority, as more services are being provided by the primary care sector and there is also an increasing need to meet the health needs of a growing and ageing population.

 

 

Simon Laffin, Executive Chairman, commented:

 

"We have had another active quarter as we continue our strong growth. Our greater financial flexibility positions us well, while our investment strategy is continuing to generate value. Assura is increasingly well positioned to help the NHS develop the modern and effective primary care infrastructure that is so necessary for this country."

 

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Simon Laffin

Jonathan Murphy

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

Assura plc, a constituent of the FTSE 250, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2016, Assura's property portfolio was valued at £1,111 million.

 

Further information is available at www.assuraplc.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVSDEITLIR
Date   Source Headline
6th Sep 201811:04 amRNSNotice of Dividend
25th Jul 20181:29 pmRNSNotification of Major Interests in Shares
20th Jul 20181:38 pmRNSPDMR Notification
16th Jul 20187:00 amRNSScrip Dividend Declaration
12th Jul 20184:59 pmRNSPricing of £300m senior unsecured bond
10th Jul 20184:28 pmRNSResult of AGM
9th Jul 20182:49 pmRNSNotification of Major Interests in Shares
5th Jul 201810:35 amRNSPDMR notification
5th Jul 20187:00 amRNSTrading Update
4th Jul 20187:00 amRNSChairman Appointment
25th Jun 20184:10 pmRNSCommittee membership
21st Jun 20186:13 pmRNSScrip Calculation Price
7th Jun 20187:00 amRNSNotice of Dividend
7th Jun 20187:00 amRNSAnnual Report & Notice of AGM
1st Jun 201811:40 amRNSNotification of Transaction by PDMR
1st Jun 20187:00 amRNSAppointment of Non-Executive Director
23rd May 20187:00 amRNSAssura Full Year Results
16th May 20187:00 amRNSNotice of Results
27th Apr 20189:44 amRNSNotification of Major Interests in Shares
23rd Apr 20182:37 pmRNSNotification of Major Interests in Shares
23rd Apr 201812:22 pmRNSNotification of Transaction by PDMR
16th Apr 20187:25 amRNSScrip Dividend Declaration
5th Apr 20182:58 pmRNSNotification of Major Interests in Shares
3rd Apr 20187:00 amRNSDirectorate Change
22nd Mar 20183:05 pmRNSScrip Calculation Price
22nd Mar 20187:00 amRNSDirectorate Change
8th Mar 20182:28 pmRNSNotice of Dividend
22nd Feb 20181:16 pmRNSTotal Voting Rights
9th Feb 20181:28 pmRNSPDMR Notification
1st Feb 20187:00 amRNSTrading Update
15th Jan 20189:46 amRNSScrip Dividend Calculation
8th Jan 20183:59 pmRNSDebt redemption
21st Dec 20172:03 pmRNSNotification of Major Interests in Shares
21st Dec 201711:59 amRNSScrip Calculation Price
7th Dec 20174:59 pmRNSNotification of Major Interests in Shares
7th Dec 20174:56 pmRNSNotification of Major Interests in Shares
7th Dec 20173:11 pmRNSNotice of Dividend
7th Dec 201712:06 pmRNSNotification of Major Interests in Shares
7th Dec 201710:28 amRNSDirector/PDMR Shareholding
6th Dec 201710:17 amRNSNotification of Major Interests in Shares
4th Dec 201712:28 pmRNSResult of General Meeting
4th Dec 20177:00 amRNSResult of Proposed Share Issue
30th Nov 20175:29 pmRNSNotification of Major Interests in Shares
17th Nov 20177:00 amRNSCompletion of Bookbuild
16th Nov 20171:02 pmRNSPublication of Prospectus
16th Nov 20177:02 amRNSProposed Share Issue and Notice of GM
16th Nov 20177:00 amRNSInterim Results 2017
1st Nov 201711:24 amRNSTotal Voting Rights
20th Oct 201712:24 pmRNSNote issuance and increased debt facilities
18th Oct 201710:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.